1. Home
  2. GBIO vs AVD Comparison

GBIO vs AVD Comparison

Compare GBIO & AVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • AVD
  • Stock Information
  • Founded
  • GBIO 2016
  • AVD 1969
  • Country
  • GBIO United States
  • AVD United States
  • Employees
  • GBIO N/A
  • AVD N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • AVD Agricultural Chemicals
  • Sector
  • GBIO Health Care
  • AVD Industrials
  • Exchange
  • GBIO Nasdaq
  • AVD Nasdaq
  • Market Cap
  • GBIO 145.5M
  • AVD 171.3M
  • IPO Year
  • GBIO 2020
  • AVD N/A
  • Fundamental
  • Price
  • GBIO $2.44
  • AVD $6.08
  • Analyst Decision
  • GBIO Buy
  • AVD Strong Buy
  • Analyst Count
  • GBIO 4
  • AVD 3
  • Target Price
  • GBIO $7.50
  • AVD $16.67
  • AVG Volume (30 Days)
  • GBIO 65.7K
  • AVD 279.7K
  • Earning Date
  • GBIO 08-07-2024
  • AVD 11-06-2024
  • Dividend Yield
  • GBIO N/A
  • AVD 1.99%
  • EPS Growth
  • GBIO N/A
  • AVD N/A
  • EPS
  • GBIO N/A
  • AVD N/A
  • Revenue
  • GBIO $13,174,000.00
  • AVD $585,049,000.00
  • Revenue This Year
  • GBIO $99.36
  • AVD N/A
  • Revenue Next Year
  • GBIO N/A
  • AVD $4.69
  • P/E Ratio
  • GBIO N/A
  • AVD N/A
  • Revenue Growth
  • GBIO 1397.05
  • AVD 2.73
  • 52 Week Low
  • GBIO $0.86
  • AVD $4.95
  • 52 Week High
  • GBIO $4.65
  • AVD $14.28
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 47.29
  • AVD 43.18
  • Support Level
  • GBIO $2.13
  • AVD $5.61
  • Resistance Level
  • GBIO $2.49
  • AVD $6.58
  • Average True Range (ATR)
  • GBIO 0.23
  • AVD 0.26
  • MACD
  • GBIO -0.01
  • AVD 0.16
  • Stochastic Oscillator
  • GBIO 38.27
  • AVD 54.55

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About AVD American Vanguard Corporation ($0.10 Par Value)

American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.

Share on Social Networks: